EUVIMEDEUVIMED entdecken
Crossref

CX-4945 (Silmitasertib) Induces Cell Death by Impairing Lysosomal Utilization in KRAS Mutant Cholangiocarcinoma Cell Lines

DA Sol Lee, Min Woo Han, Yonghyun Kang, Chorong Kim, Seonmin Lee, Kyu-Pyo Kim, Changhoon Yoo

Anticancer Research · 2024

DOI: 10.21873/anticanres.16996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von DA Sol Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Lysosomes, Cholangiocarcinoma, Pinocytosis, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysosomesCholangiocarcinomaPinocytosisProto-Oncogene Proteins p21(ras)Casein Kinase IIPiperazinesMutationBile Duct NeoplasmsNaphthyridinesPhenazinesHumansCell Line, Tumorrab7 GTP-Binding ProteinsCell DeathApoptosisLysosomal-Associated Membrane Protein 2rab GTP-Binding Proteins

Stichwörter der Autor:innen

CK2 inhibitorCX-4945KRAScholangiocarcinomamacropinocytosis

Substanzen

silmitasertibKRAS protein, humanProto-Oncogene Proteins p21(ras)Casein Kinase IIPiperazinesrab7 GTP-Binding Proteinsrab7 GTP-binding proteins, humanLAMP2 protein, humanLysosomal-Associated Membrane Protein 2rab GTP-Binding Proteins

Autor:innen und Institutionen

  • Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.
  • University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • University of Ulsan Digestive Diseases Research Center, Seoul, Republic of Korea.
  • Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea yooc@amc.seoul.kr.

Zitieren

APA

Lee, D. S., Han, M. W., Kang, Y., Kim, C., Lee, S., Kim, K. P., & Yoo, C. (2024). CX-4945 (Silmitasertib) Induces Cell Death by Impairing Lysosomal Utilization in KRAS Mutant Cholangiocarcinoma Cell Lines. Anticancer Research. https://doi.org/10.21873/anticanres.16996

Vancouver

Lee DS, Han MW, Kang Y, Kim C, Lee S, Kim KP, et al. CX-4945 (Silmitasertib) Induces Cell Death by Impairing Lysosomal Utilization in KRAS Mutant Cholangiocarcinoma Cell Lines. Anticancer Research. 2024. doi:10.21873/anticanres.16996

BibTeX
@article{Lee2024,
  author = {Lee, DA Sol and Han, Min Woo and Kang, Yonghyun and Kim, Chorong and Lee, Seonmin and Kim, Kyu-Pyo and Yoo, Changhoon},
  title = {CX-4945 (Silmitasertib) Induces Cell Death by Impairing Lysosomal Utilization in KRAS Mutant Cholangiocarcinoma Cell Lines},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.16996}
}
Kostenlos starten →